GlaxoSmithKline plc (GSK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 105.35B |
| Enterprise value | 129.05B |
| Trailing P/E | 16.93 |
| Forward P/E | 13.85 |
| PEG ratio (5-yr expected) | 1.80 |
| Price/sales (ttm) | 2.38 |
| Price/book (mrq) | 5.37 |
| Enterprise value/revenue | 3.54 |
| Enterprise value/EBITDA | 12.87 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.29 |
| 52-week change 3 | 9.55% |
| S&P500 52-week change 3 | -8.83% |
| 52-week high 3 | 46.97 |
| 52-week low 3 | 37.80 |
| 50-day moving average 3 | 44.00 |
| 200-day moving average 3 | 42.73 |
Share statistics
| Avg vol (3-month) 3 | 5.66M |
| Avg vol (10-day) 3 | 6.62M |
| Shares outstanding 5 | 2.54B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 2.45B |
| % held by insiders 1 | 0.03% |
| % held by institutions 1 | 13.50% |
| Shares short (30 May 2022) 4 | 5.09M |
| Short ratio (30 May 2022) 4 | 0.85 |
| Short % of float (30 May 2022) 4 | N/A |
| Short % of shares outstanding (30 May 2022) 4 | 0.20% |
| Shares short (prior month 28 Apr 2022) 4 | 7.35M |
Dividends & splits
| Forward annual dividend rate 4 | 1.99 |
| Forward annual dividend yield 4 | 4.55% |
| Trailing annual dividend rate 3 | 0.75 |
| Trailing annual dividend yield 3 | 1.75% |
| 5-year average dividend yield 4 | 5.23 |
| Payout ratio 4 | 78.63% |
| Dividend date 3 | 30 Jun 2022 |
| Ex-dividend date 4 | 18 May 2022 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 11 Nov 1991 |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 14.02% |
| Operating margin (ttm) | 23.40% |
Management effectiveness
| Return on assets (ttm) | 6.36% |
| Return on equity (ttm) | 27.51% |
Income statement
| Revenue (ttm) | 36.48B |
| Revenue per share (ttm) | 14.56 |
| Quarterly revenue growth (yoy) | 31.80% |
| Gross profit (ttm) | 22.66B |
| EBITDA | 10.82B |
| Net income avi to common (ttm) | 5.11B |
| Diluted EPS (ttm) | 2.47 |
| Quarterly earnings growth (yoy) | 67.90% |
Balance sheet
| Total cash (mrq) | 13.98B |
| Total cash per share (mrq) | 5.56 |
| Total debt (mrq) | 33.35B |
| Total debt/equity (mrq) | 147.36 |
| Current ratio (mrq) | 1.19 |
| Book value per share (mrq) | 6.43 |
Cash flow statement
| Operating cash flow (ttm) | 10.16B |
| Levered free cash flow (ttm) | 7.01B |
© 2022 Yahoo. All rights reserved.
